DCF — KUAKINI MEDICAL CENTER
Enterprise Value: $-352.4M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-352.4M
Enterprise Value
$-109.1M
PV of Cash Flows
$-243.3M
PV of Terminal Value
$-391.9M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $149.0M | $-23.3M | -16.0% | $-29.6M | $-26.9M |
| Year 2 | $153.5M | $-22.4M | -15.0% | $-28.9M | $-23.9M |
| Year 3 | $158.1M | $-21.5M | -14.0% | $-28.2M | $-21.2M |
| Year 4 | $162.8M | $-21.4M | -13.0% | $-28.2M | $-19.3M |
| Year 5 | $167.7M | $-21.6M | -13.0% | $-28.7M | $-17.8M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-352.4M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$144.7M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.16113311006566877
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5